IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.78M | -5.09M | -4.94M | -3.85M | -5.09M |
| Total Depreciation and Amortization | 457.00K | 500.00K | 521.00K | 527.00K | 784.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 352.00K | 401.00K | 711.00K | 692.00K | 955.00K |
| Change in Net Operating Assets | 227.00K | -758.00K | 1.57M | -889.00K | -572.00K |
| Cash from Operations | -3.75M | -4.95M | -2.14M | -3.52M | -3.93M |
| Capital Expenditure | -233.00K | -9.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -233.00K | -9.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -62.00K | -107.00K | -111.00K | -123.00K | -234.00K |
| Issuance of Common Stock | -- | -- | 18.60M | 1.11M | 5.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 11.00K | -88.00K | -- | -- | -- |
| Cash from Financing | -51.00K | -195.00K | 18.49M | 989.00K | 5.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.03M | -5.15M | 16.35M | -2.54M | 1.34M |